摘要
心血管疾病(CVD)是导致男性和女性死亡的主要原因。与男性相比,常见的传统危险因素CVD,如高胆固醇血症,高血压和吸烟具有 高患病率在一些情况下影响妇女会更大。然而,风险因素较少和较少攻击女性,部分原因是公众健康的制造者,患者和医生对其意识减 少。大约75%的妇女的冠状动脉心脏疾病死亡可避免,如果像高胆固醇血症,高血压和吸烟心血管病危险因素得到充分的治疗。这篇叙 事综述了4心血管疾病的危险因素,即高胆固醇血症,高血压,吸烟和糖尿病的治疗。在弗雷明汉心脏研究多年后,这些风险因素被发现 在心脏病研究中,这四种是心血管疾病的发展最重要的危险因素。
关键词: 心血管疾病,糖尿病,性别,高胆固醇,高血压,吸烟
Current Medicinal Chemistry
Title:Treatment of Cardiovascular Risk Factors in Women
Volume: 22 Issue: 31
Author(s): I. Gouni-Berthold and H. K. Berthold
Affiliation:
关键词: 心血管疾病,糖尿病,性别,高胆固醇,高血压,吸烟
摘要: Cardiovascular disease (CVD) is a leading cause of death for both women and men. Common traditional risk factors for CVD, such as hypercholesterolemia, hypertension and smoking have a high prevalence in women and in some cases a greater health impact compared with men. Nevertheless, risk factors are treated less often and less aggressively in women than in men, partly due to decreased awareness on the part of public health opinion makers, patients and physicians. About seventy five percent of all coronary heart disease deaths among women could be avoided if CVD risk factors like hypercholesterolemia, hypertension and smoking are adequately treated. This narrative review discusses the treatment of the 4 CVD risk factors, namely hypercholesterolemia, hypertension, smoking and diabetes. These risk factors were examined in the Framingham Heart study and years later they were found in the INTERHEART study to be the 4 most important risk factors for the development of CVD.
Export Options
About this article
Cite this article as:
I. Gouni-Berthold and H. K. Berthold , Treatment of Cardiovascular Risk Factors in Women, Current Medicinal Chemistry 2015; 22 (31) . https://dx.doi.org/10.2174/0929867322666151001122213
DOI https://dx.doi.org/10.2174/0929867322666151001122213 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Prognostic Significance of Asymptomatic Myocardial Ischemia in Women vs. Men
Current Pharmaceutical Design Lipoprotein(a): Medical Treatment Options for an Elusive Molecule
Current Pharmaceutical Design Apolipoprotein B Antisense Inhibition -Update on Mipomersen
Current Pharmaceutical Design Algorithms and Criteria for Transcatheter Aortic Valve Replacement Patient Selection: Current Status and Future Trends
Current Pharmaceutical Design CD93: Recent Advances and Implications in Disease
Current Drug Targets Importance of Dietary Supplements to the Health
Current Nutrition & Food Science Psoriasis and Atherosclerosis: Is There a Need For Novel Biomarkers Assessing Cardiovascular Risk?
Current Pharmaceutical Design Atrial Macroreentry in Congenital Heart Disease
Current Cardiology Reviews High-Throughput Functional Genomic Methods to Analyze the Effects of Dietary Lipids
Current Pharmaceutical Biotechnology How Effective are the Lipid Modifying Medicines at Preventing Coronary Heart Disease in Patients with the Metabolic Syndrome?
Vascular Disease Prevention (Discontinued) The Roles of Parathyroid Hormone and Calcitonin in Bone Remodeling: Prospects for Novel Therapeutics
Endocrine, Metabolic & Immune Disorders - Drug Targets The Impact of Type 2 Diabetes on Women’s Health and Well-being During Their Reproductive Years: A Mixed-methods Systematic Review
Current Diabetes Reviews Subject Index To Volume 7
Current Pharmaceutical Design Plasma Level of D-dimer is an Independent Diagnostic Biomarker for Deep Venous Thrombosis in Patients with Ischemic Stroke
Current Neurovascular Research Recent Studies of Antioxidant Quinoline Derivatives
Mini-Reviews in Medicinal Chemistry Editorial (Hot Topic: Modifying Cardiovascular Risk Factors: New Markers of Cardiovascular Damage)
Current Pharmaceutical Design Variations and Abnormalities of Major Thoracic Vascular Structures
Current Medical Imaging Exploring the Management of Statin Intolerant Patients: 2016 and Beyond
Current Vascular Pharmacology Physical Function and Exercise in Older Patients with Cardiovascular and Respiratory Conditions
Current Pharmaceutical Design Novel Oral Anticoagulants in Atrial Fibrillation: Update on Apixaban
Current Cardiology Reviews